Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

Combination Treatment With Antibiotic Further Reduced Brain Lesions and Was Well Tolerated

KANSAS CITY, Mo, May 4, 2007 - New data from a randomized, double-blind study showed that a combination of Copaxone (glatiramer acetate injection) along with the oral antibiotic minocycline reduced T1 Gadolinium (Gd)-enhancing lesions of the brain by 63 percent (p=0.08) in patients with active relapsing-remitting multiple sclerosis (RRMS), as measured by magnetic resonance imaging (MRI), compared to those receiving Copaxone alone. Additionally, the nine-month study demonstrated that treatment with Copaxone in combination with minocycline reduced the number of new T2 lesions in patients by 65 percent (p=0.06). These results trended toward but did not reach statistical significance.

These data were presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, MA, April 28 - May 5, 2007.

"The results of this study indicated that further exploration of this combination is warranted, as the established effect of COPAXONE(r) on disease activity may be boosted when used in combination with minocycline for the treatment of active relapsing-remitting patients," said Luanne Metz, M.D., professor at the Department of Clinical Neuroscience of the University of Calgary, and principal investigator. "In these patients, the combination was safe and well tolerated," she added.

Minocycline is a broad-spectrum antibiotic, which is used to treat pneumonia, acne, and infections of the skin, genital and urinary systems, and the central nervous system. In a small proof-of-concept trial of 10 RRMS patients, minocycline demonstrated an 84 percent relative reduction in mean total Gd-enhancing lesions and was well tolerated, and data p
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:11/24/2014)... , Nov. 24, 2014  Marta Rendon, MD, founder of ... Boca Raton , FL and international key opinion leader in ... the United States to attend the ... Istanbul, Turkey . Here, at this gathering of over ... world renowned facial plastic surgery experts from Asia ...
(Date:11/24/2014)... , Nov. 24, 2014  GlySens Incorporated announced ... million dollar grant from the National Institute of Diabetes ... the National Institutes of Health (NIH).  The grant is ... second generation ICGM™ long term implantable glucose monitoring system.  ... and enrollment is expected to begin before the end ...
(Date:11/23/2014)... , Nov. 23, 2014 Anthera Pharmaceuticals, ... Paul F. Truex , President and Chief Executive ... Annual Piper Jaffray Healthcare Conference. Anthera ... at the Palace Hotel in New York ... Anthera Pharmaceuticals is a biopharmaceutical company focused ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2
... SAN DIEGO, March 8, 2012  Arena Pharmaceuticals, Inc. (NASDAQ: ... report fourth quarter and full year 2011 financial results after ... 2012. That same afternoon, Arena,s President and Chief Executive Officer, ... Eastern Time (2:00 p.m. Pacific Time) to discuss the financial ...
... the decision to get pregnant can take on a life ... for SpermCheck® Fertility , 42% of those who conceived ... trying. Yet just 10% say their partner shared this obsession. ... conception issues and about 50% of these infertility problems will ...
Cached Medicine Technology:Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 3Perceptions on Conception 2Perceptions on Conception 3
(Date:11/24/2014)... 2014 The Healthy Skin Care Journal, ... affordable skin care products, recently announced its launch. Located ... a wide variety of articles, tips, and evaluations about ... skincare alternatives. , According to Emily Lataille, the website’s ... includes thoroughly researched reviews, tips for the skin, and ...
(Date:11/24/2014)... November 24, 2014 Residents of retirement ... in this year’s SENIORS GOT TALENT, an annual online ... From piano players to classic crooners, to seniors partying ... older adults are indeed living young. , “SENIORS GOT ... there’s a cash prize, has always been about highlighting ...
(Date:11/24/2014)... November 24, 2014 SWAccessControl.com has ... As a matter of fact, the company is a leading ... brand new magnetic locks are available at discounted prices, up ... new range of magnetic locks. This time, all of our ... popular at home and abroad, so I have confidence in ...
(Date:11/24/2014)... November 24, 2014 Gersowitz Libo & Korek, ... has received national Tier recognition in the 2015 Edition of ... tiered ranking signals a unique combination of quality law practice ... to receive this honor and especially grateful to our clients ... honor and ranking possible,” said Jeff S. Korek, senior partner ...
(Date:11/23/2014)... 2014 For the coming special Friday, ... launched a great promotion for many products, especially the ... get the best choice with amazing discounts, up to ... , It is easy to buy colored wedding ... this selection is also famous for delicate craftsmanship, elegant ...
Breaking Medicine News(10 mins):Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... without proper attire can prevent their class from playing ... -- Inappropriate clothing can limit or prevent young children,s ... Researchers looked at 53 child-care providers from 34 child-care ... levels may vary across centers. They were surprised to ...
... 13 A surprisingly easy and low-cost system of ... with Crohn,s disease and ulcerative colitis, a study released ... an online information network, allowing caregivers to systematically collect ... and their effectiveness. Creation and use of this ...
... repeated federal violations prompts agency action , SILVER SPRING, ... behalf of the U.S. Food and Drug Administration, has filed ... Fish Inc. of Jamaica, N.Y., and two of its top ... Act. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ...
... Nov. 13 Dr. Alan Hirsch, the foremost researcher on ... finding a strong following as his latest book, SENSA® WEIGHT-LOSS ... Weight (Hilton Publishing; $23.95: ISBN: 978-0981538181) has appeared at ... relevant health and wellness categories) on Amazon.com. This is ...
... of safety and lawfulness of selling such beverages , FRIDAY, ... that they plan to look into the safety and legality ... , Prompted by a request from several states, attorneys general, ... of such drinks 30 days to show the agency why ...
... 13 CANTEL MEDICAL CORP. (NYSE: CMN ... S&P SmallCap 600 Index on a date to be announced ... of the domestic equities market and is designed to be ... to ensure that they are investable and financially viable. , ...
Cached Medicine News:Health News:Kids Kept Indoors Due to Poor Clothing Choices 2Health News:'Global Bulletin Board' Shows Promise in Child Health 2Health News:'Global Bulletin Board' Shows Promise in Child Health 3Health News:'Global Bulletin Board' Shows Promise in Child Health 4Health News:FDA Takes Action Against Seafood Processing Company, Executives 2Health News:SENSA(R) WEIGHT-LOSS PROGRAM: The Accidental Discovery That's Transforming The Way People Lose Weight Breaks the Top 500 at Amazon.com in Less Than Two Weeks of Publication 2Health News:FDA Questions Safety of Caffeinated Alcoholic Drinks 2Health News:Cantel Medical To Join S&P SmallCap 600 Index 2
For the quantitative determination of Creatine Kinase in serum....
For the qualitative determination of magnesium in serum....
For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....
Glucose reagent is used for the quantitative determination of glucose in human serum....
Medicine Products: